Conexio

Conexio Overview

Founded 2002
Founded
Status Acquired/​Merged
Employees 11
Employees
Latest Deal Type M&A
Financing Rounds 2

Conexio General Information

Description

Developer of genetic sequencing and mutation detection products and services. The company has developed and supplied a novel genetic sequencing and mutation detection products and specializes in typing used to match patients and donors for bone marrow or cord blood transplants.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Acquirer
Primary Office
  • PO BOX 1294
  • Fremantle, Western Australia 6959
  • Australia
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Conexio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conexio‘s full profile, request access.

Request a free trial

Conexio Executive Team (2)

Name Title Board Seat Contact Info
David Sayer Ph.D Co-Founder & Chief Executive Officer
Damian Goodridge Ph.D Co-Founder, Chief Software Engineer & Lead Software Developer

Conexio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Conexio‘s full profile, request access.

Request a free trial